Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Wetlands and Private Development

Autor: Seltzer, E. Manning, Steinberg, Robert E.

Columbia Journal of Environmental Law, Vol 12 No 2 (1987): Volume 12.2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b98fd4ddbca3b70e0c4d9bab86480ca

Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.

Autor: Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierorazio PM; Brady Urological Institute, The Johns Hopkins University, Baltimore, Maryland., Kleinmann N; Department of Urology, Sheba Medical Center, Ramat Gan, Israel., Gore JL; Department of Urology, University of Washington Medical Center, Seattle, Washington., Shabsigh A; Department of Urology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Hu B; Department of Urology, Loma Linda University, Loma Linda, California., Chamie K; Department of Urology, UCLA, Los Angeles, California., Godoy G; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Hubosky SG; Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania., Rivera M; Department of Urology, Mayo Clinic Health System, Rochester, Minnesota., O'Donnell M; Department of Urology, University of Iowa, Iowa City, Iowa., Quek M; Department of Urology, Loyola University Medical Center, Maywood, Illinois., Raman JD; Division of Urology, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania., Knoedler JJ; Division of Urology, Pennsylvania State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania., Scherr D; Department of Urology, Weill Medical College of Cornell University, New York, New York., Weight C; Cleveland Clinic, Glickman Urological and Kidney Institute, Cleveland, Ohio., Weizer A; Department of Urology, University of Michigan, Ann Arbor, Michigan., Woods M; Department of Urology, Loyola University Medical Center, Maywood, Illinois., Kaimakliotis H; Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana., Smith AB; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina., Linehan J; Department of Urology, John Wayne Cancer Institute, Santa Monica, California., Coleman J; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York., Humphreys MR; Department of Urology, Mayo Clinic-Phoenix, Scottsdale, Arizona., Pak R; Department of Urology, Mayo Clinic-Jacksonville, Jacksonville, Florida., Lifshitz D; Department of Urology, Rabin Medical Center, Tel Aviv, Israel., Verni M; Urology Center of Las Vegas, Las Vegas, Nevada., Klein I; UroGen Pharma, Ra'anana, Israel., Konorty M; UroGen Pharma, Ra'anana, Israel., Strauss-Ayali D; UroGen Pharma, Ra'anana, Israel., Hakim G; UroGen Pharma, Ra'anana, Israel., Seltzer E; UroGen Pharma, Princeton, New Jersey., Schoenberg M; UroGen Pharma, Princeton, New Jersey.; Department of Urology, Albert Einstein College of Medicine, Bronx, New York., Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Publikováno v: The Journal of urology [J Urol] 2022 Apr; Vol. 207 (4), pp. 779-788. Date of Electronic Publication: 2021 Dec 17.

Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.

Autor: Chevli KK; State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York., Shore ND; Atlantic Urology Clinics, Carolina Urologic Research Center, Myrtle Beach, South Carolina., Trainer A; Adult Paediatrics Urology & Urogynecology, Omaha, Nebraska., Smith AB; University of North Carolina School of Medicine, Chapel Hill, North Carolina., Saltzstein D; Urology San Antonio, San Antonio, Texas., Ehrlich Y; Rabin Medical Center, Petah-Tikva, Israel., Raman JD; Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania., Friedman B; Lady Davis Carmel Medical Center, Technicon-Israel Institute of Technology, Haifa, Israel., D'Anna R; Arkansas Urology, Little Rock, Arkansas., Morris D; Urology Associates, Nashville, Tennessee., Hu B; Loma Linda University, Loma Linda, California., Tyson M; Mayo Clinic, Scottsdale, Arizona., Sankin A; Albert Einstein College of Medicine, Bronx, New York., Kates M; Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland., Linehan J; John Wayne Cancer Institute, Santa Monica, California., Scherr D; Weill Medical College of Cornell University, New York, New York., Kester S; Urology Center of Florida, Pompano Beach, Florida., Verni M; Urology Center of Las Vegas, Las Vegas, Nevada., Chamie K; UCLA, Los Angeles, California., Karsh L; The Urology Center of Colorado, Denver, Colorado., Cinman A; Tower Urology, Los Angeles, California., Meads A; UroGen Pharma, New York, New York., Lahiri S; UroGen Pharma, New York, New York., Malinowski M; UroGen Pharma, New York, New York., Gabai N; UroGen Pharma, New York, New York., Raju S; UroGen Pharma, New York, New York., Schoenberg M; Albert Einstein College of Medicine, Bronx, New York.; UroGen Pharma, New York, New York., Seltzer E; UroGen Pharma, New York, New York., Huang WC; NYU Langone Urology Associates, New York, New York.

Publikováno v: The Journal of urology [J Urol] 2022 Jan; Vol. 207 (1), pp. 61-69. Date of Electronic Publication: 2021 Aug 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.